Increased CD163 expression is associated with acute-on-chronic hepatitis B liver failure

Table 1 Baseline characteristics of the subjects enrolled in the present study

Patients	ACHBLF	CHB	Healthy control
Cases	40	40	20
Age, yr	44.48 ± 12.28	39.45 ± 12.22	38.35 ± 11.97
Sex (male/female)	23/17	26/14	12/8
HBeAg (+)/HBeAg (-)	19/21	28/12	NA
PTA, %	45.36 ± 25.14	98.70 ± 17.56	108.00 ± 13.56
TBIL, μmol/L	322.08 ± 166.00	33.39 ± 66.35	18.65 ± 6.55
HBV DNA, log10copies/mL	322.08 ± 166.00	3.20 ± 1.44	NA
Encephalopathy grade III/IV	12.12%	0%	0%
Ascites	30.30%	0%	0%
Mortality	62.5%	0%	0%

ACHBLF: Acute-on-chronic hepatitis B liver failure; CHB: Chronic hepatitis B; HBeAg: Hepatitis B e antigen; PTA: Prothrombin activity; TBIL: Total bilirubin; HBV: Hepatitis B virus; NA: Not available.